Call Options Transactions Made in Q2 2023 in Immunovant, Inc. (IMVT)
This table provides information about the institutional ownership of Immunovant, Inc. (IMVT) during Q2 2023. The information is specifically focused on institutions that hold call options of Immunovant, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
CALL |
166K+ 103.49% |
$2.36M - $3.94M
|
326K
$8.97M
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
44.5K+ 38.13% |
$632K - $1.06M
|
161K
$4.43M
|
|
|
Aug 14, 2023
Q2 2023
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
CALL |
33.8K+ 105.3% |
$480K - $803K
|
65.9K
$1.81M
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-18.9K- 14.45% |
$268K - $449K
|
112K
$3.08M
|